Identifying novel combination for multidrug-resistant neuroblastoma with TP53 mutations 

FDA influence on advisory committees through documentation: a content analysis and survey of industry views 

Discovery of a novel HIV-1 integrase inhibitor binding site: insight into enzyme structure/function and inhibitor design 

Employing engineered exosomes for combating colon cancer and engineering CD38 as an optimized drug carrier 

Disruption of immature Sertoli cell functions by endocrine disruptors and analgesic drugs 

Investigating the complexity of the tumor microenvironment's role in drug response 

Hybrid vat photopolymerization processes for viscous photocurable and non-photocurable materials 

An iPSC-based biomarker strategy to identify neuroregenerative responders to allopregnanolone 

Robert Weissman, interview, Washington, DC, USA, 2022 - video 

Current practices in pharmaceutical container closure development 

Semi-synthesis of sclerotiorin derivatives for tau aggregate inhibition and antifungal activity 

Reprocessing of single-use medical devices: a survey investigation comparing the views of three unheard stakeholders 

Targeting cellular redox modulations for pancreatic cancer treatment 

How it hurts: culture, markets, and pain in the U.S. opioid epidemic 

Clinical research in women's reproductive health and the human immunodeficiency virus 

Temporal and spatial characterization of cisplatin treatment and emerging acute resistance in bladder cancer cells 

The "war on drugs": Why the current strategy will fail 

Computerized simulation in clinical trials: a survey analysis of industry progress 

Enhancement of biofuel enzyme activity and kinetics with azoTAB surfactants 

Robert Weissman, interview transcript, Washington, DC, USA, 2022 

Investigation of in vitro activity and in vivo safety of imipenem-relebactam alone and in combination with other anti-microbial agents against clinical isolates of M. abscessus from CF patients 

The U.S. prescription drug delivery system: A comparative analysis of policy options 

Design and discovery of small molecules inhibiting the interaction of cellular LEDGF/p75 and HIV-1 integrase 

Synergism via reactive oxygen species of fenretinide combined with other anti-neoplastic agents in preclinical models of recurrent neuroblastoma 

Observation and detection of potential addictive drug use in school-age pupils